Skip to main content
$6.55 -0.05 (-0.76%) At close · Jul 24
Market Cap
$324.26M
Shares
49.96M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.60 Open$6.83 Day$6.48–6.95 52W$3.43–15.37 Avg vol 30d198K Short int2.1M · 4.2% float · 13.0d Short vol89% Last earningsMay 14, 2026 DataJul 2025–Jul 2026 Filing10-Q · May 14

Up next

Next earnings call
Sep 28, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 14, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 18.6 · elevated Equity put/call 0.79
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +1%
      above
      Price vs 50-day avg −3%
      below
      RSI (14) 49
      neutral
      MACD trend Positive
      52-week position 27%
      mid-range
      Volume (OBV) Bullish div.
      accumulating
      Momentum
      relative strength
      Neutral
      1-month return −7%
      trailing
      6-month return +22%
      trailing
      YTD return −38%
      this year
      Relative strength +15%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $7 › 200d $7 — 50d above 200d
      Institutional flow Accumulating
      6 of 50 funds reported for Jun 30 · net +6.4K sh shares · +2 new
      Insider flow Accumulating
      Net +$999.3K over 90 days · 50% sells
      Short interest Rising
      4.22% of float · ▲ +22.8% MoM · 13.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      50 holders — 13F breadth
      Squeeze score 75
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +15%
      Y/Y
      Gross margin 53%
      contracting
      EPS growth +90%
      Y/Y
      Free cash flow $-23.0M
      Valuation P/E 5
      below peers
      Quant / Vol
      risk profile
      Very High
      Volatility 98%
      annualized · 1-yr
      Max drawdown −68%
      past year
      ATR 7.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 4 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +1% Bullish
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      49 Neutral
      MACD trend
      Positive Bullish
      52-week position
      27% Neutral
      Volume (OBV)
      Bullish div. Bullish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $7 › 200d $7 — 50d above 200d
      Institutional flow Accumulating
      6 of 50 funds reported for Jun 30 · net +6.4K sh shares · +2 new
      Insider flow Accumulating
      Net +$999.3K over 90 days · 50% sells
      Short interest Rising
      4.22% of float · ▲ +22.8% MoM · 13.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      50 holders — 13F breadth
      Price context
      position in its 52-week range
      52-wk low $3 Now $7 · 27% 52-wk high $15
      vs 200-day avg +1% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      CapsoCam Plus® patients 167,000 as of March 31, 2026

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CV
      CapsoVision, Inc
      this stock
      $324.26M -38.3% 5.0 4.2%
      ABT
      Abbott Laboratories
      $179.51B -19.2% +5.7% 28.9 1.4%
      SYK
      Stryker Corp
      $126.60B -9.0% +11.2% 38.2 1.8%
      MDT
      Medtronic plc
      $106.51B -13.9% +8.4% 22.3 1.5%
      BSX
      Boston Scientific Corp
      $65.77B -54.3% +5.5% 18.5 1.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      52
      % held
      7.7%
      Reported
      6 of 50
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      69
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      2.1M
      Days to cover
      13.0d
      Change
      +391.7K sh
      View
      Short Volume
      Short vol %
      89%
      As of
      Jul 24, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      7.4K
      Value
      $55.7K
      As of
      Jun 30, 2026
      View
      Off-Exchange
      Off-exchange %
      45.3%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$999.3K
      Buyers / Sellers
      1 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $13.6M
      Net income (FY)
      $-25.3M
      EPS diluted
      $-1.03
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 2, 2026
      This year
      9
      View
      Exempt Offerings
      Offering
      $64.8M
      Filed
      Jul 23, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 14, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      CV +3.3% -6.9% +21.8% -12.9% -38.3%
      SPY -1.7% +0.7% +6.4% -1.2% +8.3%
      vs SPY +5.0% -7.6% +15.4% -11.8% -46.5%
      Key facts CIK 1378325 CUSIP 140935107 13F (30d) 6 filings 6 filers Visit website Investor relations